Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

January 23, 2018

Study Completion Date

February 7, 2018

Conditions
COPD
Interventions
DRUG

RPL554 suspension

A dual PDE3/PDE 4 inhibitor

DRUG

Placebo

Placebo solution

Trial Locations (49)

Unknown

Clinic for pneumonology, Pleven

SHATPPD-Ruse EOOD, Rousse

Fifth MHAT - Sofia EAD, Sofia

MHAT 'Lyulin', EAD, Sofia

NMTH Tsar Boris III, Sofia

UMHAT 'Alexandrovska' EAD, Sofia

UMHAT 'Sveta Anna' AD, Sofia

Medical Center Nov, Stara Zagora

MediTrial s.r.o., Jindřichův Hradec

Plicni stredisko Teplice, Teplice

Aerzte fuer Lungen- und, Berlin

Charite Campus Mitte, Berlin

emovis GmbH, Berlin

Studienpraxis Berlin, Berlin

IKF Pneumologie GmbH & Co. KG, Frankfurt

Praxis Dr. Keller, Frankfurt

Inamed GmbH, Gauting

PRI Pulmonary Research, Großhansdorf

Hamburger Institut fuer, Hamburg

Gemeinschaftspraxis Dres, Koblenz

POIS Leipzig GbR, Leipzig

SALVUS UG Centre for Clinial Trials, Leipzig

KLB Gesundheitsforschung, Lübeck

Pneumologie Odeonsplatz, Munich

Pneumologische Praxis Pasing, München

Ballenberger Freytag Wenisch, Neu-Isenburg

Dr. Christian Schlenska, Peine

CERMED, Bialystok

Indywidualna Specjalistyczna, Bialystok

KLIMED Marek Klimkiewicz, Bychawa

Silmedic sp. z o.o., Katowice

Grazyna Pulka Specjalistyczny, Krakow

Malopolskie Centrum Alergologii, Krakow

Centrum Terapii Wspólczesnej, Lodz

Uniwersytecki Szpital Klin, Lodz

NZOZ Alergo-MEDSpecjalistyczna, Poznan

ETG Network Sp z o o, Skierniewice

Centrum Medyczne Pratia, Warsaw

Mazowieckie Centrum Medyczne, Warsaw

Centrum Badan Klinicznych, Wroclaw

Specjalistyczna Opieka, Wroclaw

S.C Angisan S.R.L, Bragadiru

S.C Clinica Pneumomedica S.R.L, Brasov

Fundatia Dr. Victor Babes, Bucharest

Spitalul Clinic de Urgenta, Bucharest

Spitalul Cl. Pneumoftiziologie, Cluj-Napoca

Spitalul CldePneumoftiziologie, Constanța

Spitalul CldePneumoftiziologie, Iași

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

Verona Pharma plc

INDUSTRY

NCT03443414 - Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients | Biotech Hunter | Biotech Hunter